Webinars

Webinars Back to resource centre 11 January 2023 Digital Health: Optimizing Clinical Trials with Patient-Centric Technology Our expert speakers will navigate you through the new field of digital health in psychiatry, to conclude which technologies look to be most promising for optimizing clinical trials, and how to successfully operationalize these digital solutions. Key discussion points How digital health can streamline

Webinars Back to resource centre 11 January 2023 Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond Despite considerable efforts by biopharmaceutical companies, late-stage trial failures have plagued the drug development process for targeting Alzheimer’s disease. So what’s the problem? Join Dr. Kenton Zavitz and Dr Robert Smith to discuss the issues surrounding the identification of patients for these early

Webinars Back to resource centre 11 January 2023 Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success This webinar was arranged to discuss the major unmet therapeutic need in schizophrenia: cognitive impairment. Despite best efforts, no drugs that have been approved for the amelioration of cognitive deficits in schizophrenia: are ineffective compounds or trial designs to blame? Join Dr Kiri

Webinars Back to resource centre 11 January 2023 Leveraging Cognitive Measures in Clinical Trials This webinar discussed the assessment of cognitive function throughout the development of drugs for both CNS and non-CNS indications. It included a discussion of methodological considerations for the design of clinical trials and approaches to the analysis and interpretation of cognitive outcome measures for the evaluation

Webinars Back to resource centre 11 January 2023 Understanding the Clinical Assessment of Abuse Potential during CNS Drug Development This free webinar discussed the why, when and how of collecting, evaluating and interpreting abuse potential data throughout CNS drug development, including a discussion of the design, analysis and interpretation of human abuse potential studies.  Speaker: Kerri A. Schoedel, PhD, Director and

Webinars Back to resource centre 11 January 2023 Assessing Cognitive Safety of Drugs in Clinical Development In this webinar, Dr Kenton Zavitz, Director of Clinical Affairs discusses assessing cognitive safety of drugs in clinical development.  Speakers: Kenton H. Zavitz, PhD, Director of Clinical Affairs Pradeep Nathan, PhD, Vice President Neuroscience Scientific Strategy Lead and Head, Neuroscience Center of Innovation, inVentiv Health Key Discussion Points: What